Shopping Cart
- Remove All
- Your shopping cart is currently empty
TGFβ1-IN-3, a diarylhydrazone derivative, inhibits fibroblast activation and proliferation, positioning it as a candidate compound for the treatment of idiopathic pulmonary fibrosis (IPF).
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $195 | In Stock | |
5 mg | $483 | In Stock | |
10 mg | $692 | In Stock | |
25 mg | $1,080 | In Stock | |
50 mg | $1,490 | In Stock | |
100 mg | $1,970 | In Stock | |
500 mg | $3,930 | In Stock |
Description | TGFβ1-IN-3, a diarylhydrazone derivative, inhibits fibroblast activation and proliferation, positioning it as a candidate compound for the treatment of idiopathic pulmonary fibrosis (IPF). |
In vitro | TGFβ1-IN-3 (compound 44) inhibits NIH-3T3 cells with an IC50 of 0.57 μM. At 10 μM for 24 hours, it inhibits TGF-β1-induced abnormal activation of NIH-3T3 and A549 cells, as well as migration and epithelial-mesenchymal transition (EMT) of A549 cells. TGFβ1-IN-3 binds to STAT3, interacting with Ile659, while the hydrophilic piperidine forms intermolecular forces with Ser636, Arg609, and Pro639. The nitrofuran of TGFβ1-IN-3 interacts with Lys658.[1] |
In vivo | TGFβ1-IN-3 (compound 44) administered orally at 30-60 mg/kg once daily for 22 days in C57BL/6 mice slows IPF progression and enhances lung function, potentially reversing pulmonary fibrosis in a treatment model.[1] |
Molecular Weight | 442.51 |
Formula | C23H30N4O5 |
Cas No. | 2883813-58-7 |
Smiles | C(=N/NC(=O)C1=CC=C(OCCCCCCN2CCCCC2)C=C1)\C=3OC(N(=O)=O)=CC3 |
Storage | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 45 mg/mL (101.69 mM) ![]() | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.